74 results
6-K
EX-5.1
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Current report (foreign)
5:29pm
and have not performed any independent check or verification of such factual matters.
In giving this opinion, we have assumed the genuineness of all
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Current report (foreign)
5:29pm
Statement and the Prospectus. To the knowledge of the Company, such accountants are independent public accountants as required by Canadian Securities … ) and are an independent registered public accounting firm within the meaning of the Securities Act and the applicable rules and regulations thereunder
424B5
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Prospectus supplement for primary offering
5:26pm
is not guaranteed and has not been verified by any independent sources. Market and industry data, including estimates and projections relating to size of market … 1400, Minneapolis, MN 55402. Grant Thornton LLP is independent from the Company within the meaning of the rules of professional conduct of the Chartered
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
14 Dec 23
Immunoprecise Antibodies LTD. 6-K
8:03am
to conduct an independent review of the asset under contemplation of an out-licensing. Simultaneously, the Company's marketing partnerships are enhancing
424B5
IPA
ImmunoPrecise Antibodies Ltd
7 Dec 23
Prospectus supplement for primary offering
4:53pm
and forecasts that are based on independent industry publications and other publicly available information. Although we believe these sources are reliable … is not guaranteed and has not been verified by any independent sources. Market and industry data, including estimates and projections relating to size of market
6-K
EX-5.1
pebn4q
6 Dec 23
Current report (foreign)
5:19pm
6-K
EX-10.1
rpq82nk sg2
6 Dec 23
Current report (foreign)
5:19pm
6-K
EX-8.1
v8yym4arm 2fkvke0x6
6 Dec 23
Current report (foreign)
5:19pm
424B5
ycq9j
5 Dec 23
Prospectus supplement for primary offering
4:02pm
6-K
EX-99.1
6033x
20 Oct 23
Current report (foreign)
2:56pm
6-K
EX-99.1
i1vp9n1
18 Sep 23
Statement of Executive Compensation
2:47pm
6-K
EX-99.1
jve228p
12 Sep 23
Material Change Report
6:20pm
6-K
EX-99.1
ll7xxqjd
5 Sep 23
IPA appoints Barry A. Springer, Dirk Witters and Chris Buyse to the Board of Directors
8:14am
6-K
EX-10.1
u81oo12nu 09f
15 Aug 23
Current report (foreign)
5:50pm
424B5
2ugydyfm8
15 Aug 23
Prospectus supplement for primary offering
5:47pm
F-3
rj237 e22
10 Jul 23
Shelf registration (foreign)
7:04pm
F-3
EX-23.2
c1v1sc 2tn17uc
10 Jul 23
Shelf registration (foreign)
7:04pm
F-3
EX-4.3
mlnpv60zj6xaoo7cys
10 Jul 23
Shelf registration (foreign)
7:04pm
40-F
EX-99.2
rkcr m8kwcycwqpoaop
10 Jul 23
Annual report (Canada)
4:32pm
40-F
EX-99.1
sh5tj
10 Jul 23
Annual report (Canada)
4:32pm